Rapid Screening for Exposure to "non-Target" Pharmaceuticals from Wastewater Effluents by Combining HRMS-Based Suspect Screening and Exposure Modeling

Environmental Science and Technology

Volumn 50, Issue 13, 2016, Pages 6698-6707

  Singer, Heinz P ^a   Wössner, Annika E ^a,b   McArdell, Christa S ^a   Fenner, Kathrin ^a,b  

^a SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED SLUDGE PROCESS; BIOCHEMISTRY; ECOLOGY; ECOSYSTEMS; IONIZATION POTENTIAL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; WASTEWATER TREATMENT; WATER RESOURCES;

ACTIVATED SLUDGE TREATMENT; ACTIVE PHARMACEUTICAL INGREDIENTS; ANALYTICAL METHOD DEVELOPMENT; AQUATIC ENVIRONMENTS; HIGH RESOLUTION MASS SPECTROMETRY; STATE OF THE PRACTICE; WASTEWATER EFFLUENTS; WASTEWATER TREATMENT PLANT EFFLUENT;

EFFLUENTS;

ACTIVATED SLUDGE; ANALYTICAL METHOD; AQUATIC ENVIRONMENT; BIOACCUMULATION; DRUG; ECOSYSTEM HEALTH; LIQUID CHROMATOGRAPHY; MASS BALANCE; SURFACE WATER; WASTEWATER; WATER RESOURCE;

ACTIVATED SLUDGE; ANALYTIC METHOD; AQUATIC ENVIRONMENT; BIOACCUMULATION; EFFLUENT; EXPOSURE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLANT MODEL; SCREENING; ENVIRONMENTAL MONITORING; SEWAGE; THEORETICAL MODEL; WASTE WATER; WATER POLLUTANT;

APIS;

DRUG; SEWAGE; WASTE WATER; WATER POLLUTANT;

CHROMATOGRAPHY, LIQUID; ENVIRONMENTAL MONITORING; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; SEWAGE; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84979022042     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/acs.est.5b03332     Document Type: Article

References (55)

1. Halling-Sørensen, B.; Nors Nielsen, S.; Lanzky, P. F.; Ingerslev, F.; Holten Lützhøft, H. C.; Jørgensen, S. E. Occurrence, fate and effects of pharmaceutical substances in the environment- A review Chemosphere 1998, 36, 357-393 10.1016/S0045-6535(97)00354-8
2. Petrie, B.; Barden, R.; Kasprzyk-Hordern, B. A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring Water Res. 2015, 72, 3-27 10.1016/j.watres.2014.08.053
3. Overturf, M. D.; Anderson, J. C.; Pandelides, Z.; Beyger, L.; Holdway, D. A. Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction Crit. Rev. Toxicol. 2015, 45, 469-491 10.3109/10408444.2015.1038499
4. Fent, K.; Weston, A. A.; Caminada, D. Ecotoxicology of human pharmaceuticals Aquat. Toxicol. 2006, 76, 122-159 10.1016/j.aquatox.2005.09.009
5. Boxall, A. B. A.; Johnson, P.; Smith, E. J.; Sinclair, C. J.; Stutt, E.; Levy, L. S. Uptake of veterinary medicines from soils into plants J. Agric. Food Chem. 2006, 54, 2288-2297 10.1021/jf053041t
6. Heeb, F.; Singer, H.; Pernet-Coudrier, B.; Qi, W. X.; Liu, H. J.; Longree, P.; Muller, B.; Berg, M. Organic Micropollutants in Rivers Downstream of the Megacity Beijing: Sources and Mass Fluxes in a Large-Scale Wastewater Irrigation System Environ. Sci. Technol. 2012, 46, 8680-8688 10.1021/es301912q
7. Loos, R.; Locoro, G.; Comero, S.; Contini, S.; Schwesig, D.; Werres, F.; Balsaa, P.; Gans, O.; Weiss, S.; Blaha, L.; Bolchi, M.; Gawlik, B. M. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water Water Res. 2010, 44, 4115-4126 10.1016/j.watres.2010.05.032
8. Lapworth, D. J.; Baran, N.; Stuart, M. E.; Ward, R. S. Emerging organic contaminants in groundwater: A review of sources, fate and occurrence Environ. Pollut. 2012, 163, 287-303 10.1016/j.envpol.2011.12.034
9. Vergeynst, L.; Van Langenhove, H.; Demeestere, K. Trends in liquid chromatography coupled to high-resolution mass spectrometry for multi-residue analysis of organic micropollutants in aquatic environments TrAC, Trends Anal. Chem. 2015, 67, 192-208 10.1016/j.trac.2015.01.010
10. Hernández, F.; Ibáñez, M.; Bade, R.; Bijlsma, L.; Sancho, J. V. Investigation of pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass spectrometry TrAC, Trends Anal. Chem. 2014, 63, 140-157 10.1016/j.trac.2014.08.003
11. Petrovic, M.; Farré, M.; de Alda, M. L.; Perez, S.; Postigo, C.; Köck, M.; Radjenovic, J.; Gros, M.; Barcelo, D. Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples J. Chromatogr. A 2010, 1217, 4004-4017 10.1016/j.chroma.2010.02.059
12. Wille, K.; De Brabander, H. F.; Vanhaecke, L.; De Wulf, E.; Van Caeter, P.; Janssen, C. R. Coupled chromatographic and mass-spectrometric techniques for the analysis of emerging pollutants in the aquatic environment TrAC, Trends Anal. Chem. 2012, 35, 87-108 10.1016/j.trac.2011.12.003
13. Vazquez-Roig, P.; Blasco, C.; Picó, Y. Advances in the analysis of legal and illegal drugs in the aquatic environment TrAC, Trends Anal. Chem. 2013, 50, 65-77 10.1016/j.trac.2013.04.008
14. de Voogt, P.; Janex-Habibi, M. L.; Sacher, F.; Puijker, L.; Mons, M. Development of a common priority list of pharmaceuticals relevant for the water cycle Water Sci. Technol. 2009, 59, 39-46 10.2166/wst.2009.764
15. Caldwell, D. J.; Mastrocco, F.; Margiotta-Casaluci, L.; Brooks, B. W. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessmerit, monitoring and advanced research Chemosphere 2014, 115, 4-12 10.1016/j.chemosphere.2014.01.021
16. Cooper, E. R.; Siewicki, T. C.; Phillips, K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment Sci. Total Environ. 2008, 398, 26-33 10.1016/j.scitotenv.2008.02.061
17. Besse, J. P.; Garric, J. Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation Toxicol. Lett. 2008, 176, 104-123 10.1016/j.toxlet.2007.10.012
18. Wennmalm, A.; Gunnarsson, B. Public health care management of water pollution with pharmaceuticals: Environmental classification and analysis of pharmaceutical residues in sewage water Drug Inf. J. 2005, 39, 291-297 10.1177/009286150503900307
19. Sanderson, H.; Johnson, D. J.; Reitsma, T.; Brain, R. A.; Wilson, C. J.; Solomon, K. R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters Regul. Toxicol. Pharmacol. 2004, 39, 158-183 10.1016/j.yrtph.2003.12.006
20. Kumar, A.; Xagoraraki, I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Sci. Total Environ. 2010, 408, 5972-5989 10.1016/j.scitotenv.2010.08.048
21. Munoz, I.; Gomez, M. J.; Molina-Diaz, A.; Huijbregts, M. A. J.; Fernandez-Alba, A. R.; Garcia-Calvo, E. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment Chemosphere 2008, 74, 37-44 10.1016/j.chemosphere.2008.09.029
22. Huggett, D. B.; Cook, J. C.; Ericson, J. F.; Williams, R. T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish Hum. Ecol. Risk Assess. 2003, 9, 1789-1799 10.1080/714044797
23. Kostich, M. S.; Lazorchak, J. M. Risks to aquatic organisms posed by human pharmaceutical use Sci. Total Environ. 2008, 389, 329-339 10.1016/j.scitotenv.2007.09.008
24. Perazzolo, C.; Morasch, B.; Kohn, T.; Magnet, A.; Thonney, D.; Chevre, N. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: Priority list for environmental risk assessment of pharmaceuticals Environ. Toxicol. Chem. 2010, 29, 1649-1657 10.1002/etc.221
25. Diamond, J. M.; Latimer, H. A., II; Munkittrick, K. R.; Thornton, K. W.; Bartell, S. M.; Kidd, K. A. Prioritizing Contaminants of Emerging Concern for Ecological Screening Assessments Environ. Toxicol. Chem. 2011, 30, 2385-2394 10.1002/etc.667
26. Howard, P. H.; Muir, D. C. G. Identifying New Persistent and Bioaccumulative Organics Among Chemicals in Commerce II: Pharmaceuticals Environ. Sci. Technol. 2011, 45, 6938-6946 10.1021/es201196x
27. Berninger, J. P.; Brooks, B. W. Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals Toxicol. Lett. 2010, 193, 69-78 10.1016/j.toxlet.2009.12.006
28. Christen, V.; Hickmann, S.; Rechenberg, B.; Fent, K. Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action Aquat. Toxicol. 2010, 96, 167-181 10.1016/j.aquatox.2009.11.021
29. Andersson, P. L.; Fick, J.; Rannar, S. A Multivariate Chemical Similarity Approach to Search for Drugs of Potential Environmental Concern J. Chem. Inf. Model. 2011, 51, 1788-1794 10.1021/ci200107b
30. Roos, V.; Gunnarsson, L.; Fick, J.; Larsson, D. G. J.; Ruden, C. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection Sci. Total Environ. 2012, 421, 102-110 10.1016/j.scitotenv.2012.01.039
31. Krauss, M.; Singer, H.; Hollender, J. Anal. Bioanal. Chem Anal. Bioanal. Chem. 2010, 397, 943-951 10.1007/s00216-010-3608-9
32. Schymanski, E.; Jeon, J.; Gulde, R.; Fenner, K.; Ruff, M.; Singer, H.; Hollender, J. Identifying small molecules via high resolution mass spectrometry: Communicating confidence Environ. Sci. Technol. 2014, 48, 2097-2098 10.1021/es5002105
33. Kern, S.; Fenner, K.; Singer, H. P.; Schwarzenbach, R. P.; Hollender, J. Identification of Transformation Products of Organic Contaminants in Natural Waters by Computer-Aided Prediction and High-Resolution Mass Spectrometry Environ. Sci. Technol. 2009, 43, 7039-7046 10.1021/es901979h
34. Moschet, C.; Piazzoli, A.; Singer, H.; Hollender, J. Alleviating the Reference Standard Dilemma Using a Systematic Exact Mass Suspect Screening Approach with Liquid Chromatography-High Resolution Mass Spectrometry Anal. Chem. 2013, 85, 10312-10320 10.1021/ac4021598
35. Vergeynst, L.; Van Langenhove, H.; Demeestere, K. Balancing the False Negative and Positive Rates in Suspect Screening with High-Resolution Orbitrap Mass Spectrometry Using Multivariate Statistics Anal. Chem. 2015, 87, 2170-2177 10.1021/ac503426k
36. IMS Health GmbH. Consumption of pharmaceuticals in Switzerland. Data purchased byEawag, (2009.
37. IMS Health GmbH. Consumption of pharmaceuticals in Germany (IMS MIDAS® 2009).Data purchased by Umweltbundesamt, (2009.
38. Bergmann, A.; Fohrmann, R.; Weber, F.-A. Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln, Texte 66/2011; Umweltbundesamt: Dessau-Rosslau, Germany, 2011.
39. Besse, J. P.; Kausch-Barreto, C.; Garric, J. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritization Hum. Ecol. Risk Assess. 2008) 14, 665-695 10.1080/10807030802235078
40. Bisceglia, K. J. Occurrence and Fate of Pharmaceuticals, Illicit Drugs, And Other Emerging Contaminants in Natural and Engineered Environments; Johns Hopkins University: Baltimore, MD, 2010.
41. Helbling, D. E.; Hollender, J.; Kohler, H.-P. E.; Fenner, K. High-throughput identification of microbial transformation products of organic micropollutants Environ. Sci. Technol. 2010, 44, 6621-6627 10.1021/es100970m
42. Schymanski, E. L.; Singer, H. P.; Longrée, P.; Loos, M.; Ruff, M.; Stravs, M. A.; Ripollés Vidal, C.; Hollender, J. Strategies to Characterize Polar Organic Contamination in Wastewater: Exploring the Capability of High Resolution Mass Spectrometry Environ. Sci. Technol. 2014, 48, 1811-1818 10.1021/es4044374
43. Ruff, M.; Mueller, M. S.; Loos, M.; Singer, H. P. Quantitative target and systematic non-target analysis of polar organic micro-pollutants along the river Rhine using high-resolution mass-spectrometry-Identification of unknown sources and compounds Water Res. 2015, 87, 145-154 10.1016/j.watres.2015.09.017
44. Schymanski, E. L.; Singer, H. P.; Slobodnik, J.; Ipolyi, I. M.; Oswald, P.; Krauss, M.; Schulze, T.; Haglund, P.; Letzel, T.; Grosse, S.; Thomaidis, N. S.; Bletsou, A.; Zwiener, C.; Ibanez, M.; Portoles, T.; de Boer, R.; Reid, M. J.; Onghena, M.; Kunkel, U.; Schulz, W.; Guillon, A.; Noyon, N.; Leroy, G.; Bados, P.; Bogialli, S.; Stipanicev, D.; Rostkowski, P.; Hollender, J. Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis Anal. Bioanal. Chem. 2015, 407, 6237-6255 10.1007/s00216-015-8681-7
45. Singer, H.; Loos, M.; Schymanski, E. enviMass version 1.2. http://www.eawag.ch/en/department/uchem/software/envimass/ (accessed July 2, 2015).
46. Loos, M.; Gerber, C.; Corona, F.; Hollender, J.; Singer, H. Accelerated Isotope Fine Structure Calculation Using Pruned Transition Trees Anal. Chem. 2015, 87, 5738-5744 10.1021/acs.analchem.5b00941
47. EMEA. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use; Committee for Medicinal Products for Human Use (CHMP); European Medicines Agency (EMEA): London, 01 June, 2006; p 12.
48. Arzneimittelkompendium. http://www.compendium.ch (accessed: July 9, 2015).
49. Lienert, J.; Gudel, K.; Escher, B. I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes Environ. Sci. Technol. 2007, 41, 4471-4478 10.1021/es0627693
50. U.S. Environmental Protection Agency. Estimation ProgramsInterface Suite for Microsoft® Windows (EPI Suite), v 4.00. http://www.epa.gov/opptintr/exposure/pubs/episuitedl.htm (accessed: July 4, 2012).
51. Clara, M.; Strenn, B.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants Water Res. 2005, 39, 4797-4807 10.1016/j.watres.2005.09.015
52. Helbling, D. E.; Johnson, D. R.; Honti, M.; Fenner, K. Micropollutant Biotransformation Kinetics Associate with WWTP Process Parameters and Microbial Community Characteristics Environ. Sci. Technol. 2012, 46, 10579-10588 10.1021/es3019012
53. Yang, C.; Zhang, W.; Liu, R.; Li, Q.; Li, B.; Wang, S.; Song, C.; Qiao, C.; Mulchandani, A. Phylogenetic Diversity and Metabolic Potential of Activated Sludge Microbial Communities in Full-Scale Wastewater Treatment Plants Environ. Sci. Technol. 2011, 45, 7408-7415 10.1021/es2010545
54. Van Doorslaer, X.; Dewulf, J.; Van Langenhove, H.; Demeestere, K. Fluoroquinolone antibiotics: An emerging class of environmental micropollutants Sci. Total Environ. 2014, 500, 250-269 10.1016/j.scitotenv.2014.08.075
55. Michael, I.; Rizzo, L.; McArdell, C. S.; Manaia, C. M.; Merlin, C.; Schwartz, T.; Dagot, C.; Fatta-Kassinos, D. Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review Water Res. 2013, 47, 957-995 10.1016/j.watres.2012.11.027